HHS Drafts Proposal To Improve Human Research Regulations
This article was originally published in The Gray Sheet
Citing concerns over outdated regulations, HHS is recommending multi-site institutional review board reviews, updated informed-consent processes and revised risk calculations, among other changes, in a wide-reaching proposal to improve protections for human research subjects.
You may also be interested in...
If adopted, the proposal would supersede the FDA’s 1998 Guide to Informed Consent, and comes as HHS is considering changes to the so-called “Common Rule” for human subject protection.
The costs associated with more expansive sharing of clinical trial data for independent research would be significant, experts warned at a meeting convened by the Institute of Medicine to help inform a planned study on strategies for increasing trial data-sharing.
Regulations agenda includes a proposed rule to establish standardized symbols in medical device labeling, as well as plans to issue the unique device identification final rule.